FindTrial
Sign In

Clinical epidemiological characteristics and long-term follow-up study of pediatric myasthenia gravis

Clinical epidemiological characteristics and long-term follow-up study of pediatric myasthenia gravis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024510
Enrollment
Unknown
Registered
2019-07-13
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myasthenia gravis

Interventions

Case series:None

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. From August 2019 to December 2039, children with pediatric myasthenia gravis were admitted to the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine; 2. Aged <=18 years; 3. The legal guardian of the child signs the informed consent.

Exclusion criteria

Exclusion criteria: 1. Myasthenia gravis is not treated for other diseases, or there are serious systemic diseases; 2. Children and their families can not accurately describe the condition in detail.

Design outcomes

Primary

MeasureTime frame
MGC scores;PRO scale;ADL grade;MGFA classification;Glucocorticoid dosage;the occurrence of myasthenic crisis;recurrence rate;mortality;—

Countries

China

Contacts

Public ContactQilong Jiang

Department of Spleen-Stomach, The First Affiliated Hospital of Guangzhou University of Chinese Medicine

jqllpzx@126.com+86 15989082142

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026